GBT
ARKG icon

Grove Bank & Trust’s ARK Genomic Revolution ETF ARKG Stock Holding History

Grove Bank & Trust’s Portfolio ARKG Stock Details ARKG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-59
Closed -$1.77K – 641
2023
Q1 		$1.77K Hold
59
– – ﹤0.01% 651
2022
Q4 		$2K Buy
+59
New +$1.87K ﹤0.01% 565

Other funds holding ARKG

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
State of Wisconsin Investment Board
State of Wisconsin Investment Board Madison, Wisconsin $43.7B AUM 27.76% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Grove Bank & Trust's ARKG Position: Q2 2023 in Review

Grove Bank & Trust sold out of ARK Genomic Revolution ETF (ARKG) in Q2 2023, closing a stake of 59 shares — an estimated $1.77K sold.

Grove Bank & Trust first reported a position in ARKG in Q4 2022 and held it in 2 quarters. The position peaked at $2K in Q4 2022. 290 funds tracked by Wall St. Rank hold ARKG as of Q2 2023.

  • Grove Bank & Trust reported no remaining ARK Genomic Revolution ETF position as of Q2 2023 after selling out during the quarter.
  • Grove Bank & Trust sold 59 ARK Genomic Revolution ETF shares in Q2 2023, an estimated $1.77K.
  • Grove Bank & Trust first reported a position in ARK Genomic Revolution ETF in Q4 2022 and held it in 2 quarters.
  • Grove Bank & Trust's ARK Genomic Revolution ETF position peaked at $2K in Q4 2022.
  • 290 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q2 2023.

Based on Grove Bank & Trust's 13F filing for Q2 2023, filed 27 Jul 2023.